STOCK TITAN

VSee Health (NASDAQ: VSEE) wins approval for reverse stock split authority

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

VSEE HEALTH, INC. (VSEE) reported the results of its August 25, 2026 annual meeting of stockholders. Common stock outstanding as of the July 6, 2026 record date was 55,679,813 shares, and 121.698 shares of preferred stock were outstanding; holders representing 50.65% of combined voting power were present, constituting a quorum.

Stockholders elected Kevin Lowdermilk and Colin O’Sullivan as directors until the 2029 annual meeting. They also ratified WWC, P.C. as independent registered public accounting firm for the year ending December 31, 2026. In addition, stockholders approved giving the board discretionary authority to implement one or more Reverse Stock Splits of the common stock within a range of 1-for-20 up to 1-for-80, provided aggregate splits do not exceed 1-for-80 and any reverse split is completed no later than the second anniversary of the record date. An adjournment proposal related to these items was also approved.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Common stock outstanding at record date 55,679,813 shares Common stock outstanding as of July 6, 2026 record date
Preferred stock voting power 12,169.8 votes Votes entitled from 121.698 preferred shares at the annual meeting
Shares represented at meeting 28,208,699 shares Common and preferred shares present in person or by proxy
Quorum percentage 50.65% Percentage of total outstanding shares entitled to vote represented
Reverse Stock Split authority range 1-for-20 to 1-for-80 Approved ratios for potential Reverse Stock Splits of common stock
Reverse Stock Split votes for 26,433,405 Votes in favor of granting reverse split authority
Auditor ratification votes for 27,539,111 Votes to ratify WWC, P.C. as independent registered public accounting firm
Director Lowdermilk votes for 18,300,518 Votes for election of Kevin Lowdermilk as director
Reverse Stock Split financial
"effect one or more consolidations of the issued and outstanding shares of Common Stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
broker non-votes regulatory
"ABSTAIN | | BROKER NON-VOTES 26,433,405 | | 1,748,270 | | 27,024 | | -"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
quorum regulatory
"representing 50.65% of the total outstanding shares ... constituting a quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
adjourn the Annual Meeting regulatory
"approved of a proposal to adjourn the Annual Meeting to a later date or dates"
independent registered public accounting firm financial
"ratified the appointment of WWC, P.C. as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

FAQ

What did VSEE stockholders approve at the August 25, 2026 annual meeting?

Stockholders elected two directors, ratified WWC, P.C. as auditor for 2026, approved discretionary authority for the board to execute one or more Reverse Stock Splits within a 1-for-20 to 1-for-80 range, and approved an adjournment proposal related to these matters.

What Reverse Stock Split authority did VSEE (VSEE) stockholders grant?

Stockholders approved granting the board authority to effect one or more Reverse Stock Splits combining and reclassifying issued and outstanding common stock at ratios between 1-for-20 and 1-for-80, so long as splits in aggregate do not exceed 1-for-80 and are completed within two years of the record date.

How many VSEE (VSEE) shares were entitled to vote at the 2026 annual meeting?

As of the July 6, 2026 record date, there were 55,679,813 common shares outstanding entitled to 55,679,813 votes and 121.698 preferred shares outstanding entitled to an aggregate of 12,169.8 votes at the annual meeting.

What quorum was present at VSEE’s 2026 annual meeting?

Holders of 28,208,699 shares of common and preferred stock were present in person or by proxy, representing 50.65% of the total outstanding shares entitled to vote, which constituted a quorum under the company’s bylaws.

What were the vote results on the VSEE Reverse Stock Split proposal?

The Reverse Stock Split authority proposal received 26,433,405 votes for, 1,748,270 against, 27,024 abstentions, and no broker non-votes, resulting in approval of the discretionary authority for the board.

Who was elected to VSEE’s board at the 2026 annual meeting?

Stockholders elected Kevin Lowdermilk and Colin O’Sullivan as directors to serve until the 2029 annual meeting or until their successors are duly elected or appointed and qualified.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001864531 0001864531 2026-08-25 2026-08-25 0001864531 VSEE:CommonStock0.0001ParValuePerShareMember 2026-08-25 2026-08-25 0001864531 VSEE:WarrantsWhichEntitlesHolderToPurchaseOne1ShareOfCommonStockAtPriceOf11.50PerWholeShareMember 2026-08-25 2026-08-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 26, 2026 (August 25, 2026)

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol   Name of each exchange on
which registered
Common Stock, $0.0001 par value per share   VSEE   OTC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   OTC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On August 25, 2026, VSee Health, Inc., a Delaware Corporation (the “Company”), held its annual meeting of stockholders for its fiscal year ended December 31, 2026 (the “Annual Meeting”). As of July 6, 2026, the record date for the Annual Meeting (the “Record Date”), there were 55,679,813 shares of common stock, par value $0.0001 per share (“Common Stock”), outstanding, which shares were entitled to an aggregate of 55,679,813 votes at the Annual Meeting, and 121.698 shares of preferred stock (“Preferred Stock”) outstanding, which shares were entitled to an aggregate of 12,169.8 votes at the annual meeting. Holders of 28,208,699 shares of the Company’s Common Stock and Preferred Stock were present in person or by proxy at the Annual Meeting, representing 50.65% of the total outstanding shares of Common Stock and Preferred Stock entitled to vote at the Annual Meeting, constituting a quorum pursuant to the Company’s bylaws, as amended. At the Annual Meeting, four proposals were submitted to the Company’s stockholders. A brief summary of the matters voted upon by stockholders at the Annual Meeting is set forth below, and the proposals are described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on July 20, 2026 (the “Proxy Statement”). The voting results reported below are final.

 

Proposal 1: The Directors Proposal

 

The Company’s stockholders elected Kevin Lowdermilk and Colin O’Sullivan as members of the Company’s board of directors (the “Board”), each to hold office until the 2029 annual meeting of stockholders or until their respective successors shall have been duly elected or appointed and qualified, based upon the following votes:

 

   FOR  AGAINST  ABSTAIN  BROKER NON-VOTES
Kevin Lowdermilk  18,300,518  1,108,736  25,119  8,774,326
Colin O’Sullivan  18,324,565  1,090,558  19,250  8,774,326

 

Proposal 2: The Auditor Proposal

 

The Company’s stockholders ratified the appointment of WWC, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, based upon the following votes:

 

FOR  AGAINST  ABSTAIN
27,539,111  662,101  7,487

 

Proposal 3: The Reverse Stock Split Proposal

 

The Company’s stockholders approved the proposal to grant discretionary authority to the Board to amend the Certificate of Incorporation to effect one or more consolidations of the issued and outstanding shares of Common Stock, pursuant to which the shares of Common Stock would be combined and reclassified into one share of Common Stock at a ratio within the range from 1-for-20 up to 1-for-80 (each, a “Reverse Stock Split”), provided that, (X) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed 1-for-80, and (Y) any Reverse Stock Split is completed no later than the second anniversary of the Record Date, as detailed in the Proxy Statement, based upon the following votes:

 

FOR  AGAINST  ABSTAIN  BROKER NON-VOTES
26,433,405  1,748,270  27,024  -

 

Proposal 4: The Adjournment Proposal

 

The Company’s stockholders approved of a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there were insufficient votes for, or otherwise in connection with, the approval of any of the foregoing proposals, based upon the following votes:

 

FOR  AGAINST  ABSTAIN
24,507,566  3,648,049  53,084

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 26, 2026 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name:  Imoigele Aisiku
  Title: Chief Executive Officer

 

 

 

 2

 

Filing Exhibits & Attachments

4 documents